Literature DB >> 17121800

Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.

Prabal Banerjee1, Rosemary Rochford, J Antel, G Canute, Stephen Wrzesinski, Michelle Sieburg, Gerold Feuer.   

Abstract

Infection with human T-cell leukemia virus type 1 (HTLV-1) can result in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic inflammatory disease of the central nervous system (CNS). HTLV-2 is highly related to HTLV-1 at the genetic level and shares a high degree of sequence homology, but infection with HTLV-2 is relatively nonpathogenic compared to HTLV-1. Although the pathogenesis of HAM/TSP remains to be fully elucidated, previous evidence suggests that elevated levels of the proinflammatory cytokines in the CNS are associated with neuropathogenesis. We demonstrate that HTLV-1 infection in astrogliomas results in a robust induction of interleukin-1beta (IL-1beta), IL-1alpha, tumor necrosis factor alpha (TNF-alpha), TNF-beta, and IL-6 expression. HTLV encodes for a viral transcriptional transactivator protein named Tax that also induces the transcription of cellular genes. To investigate and compare the effects of Tax1 and Tax2 expression on the dysregulation of proinflammatory cytokines, lentivirus vectors were used to transduce primary human astrocytomas and oligodendrogliomas. The expression of Tax1 in primary human astrocytomas and oligodendrogliomas resulted in significantly higher levels of proinflammatory cytokine gene expression compared to Tax2. Notably, Tax1 expression uniquely sensitized primary human astrocytomas to apoptosis. A Tax2/Tax1 chimera encoding the C-terminal 53 amino acids of the Tax1 fused to the Tax2 gene (Tax(221)) demonstrated a phenotype that resembled Tax1, with respect to proinflammatory cytokine gene expression and sensitization to apoptosis. The patterns of differential cytokine induction and sensitization to apoptosis displayed by Tax1 and Tax2 may reflect differences relating to the heightened neuropathogenicity associated with HTLV-1 infection and the development of HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121800      PMCID: PMC1797548          DOI: 10.1128/JVI.01513-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  HTLV-I induced myeloneuropathy in WKAH rats: apoptosis and local activation of the HTLV-I pX and TNF-alpha genes implicated in the pathogenesis.

Authors:  O Ohya; U Tomaru; I Yamashita; T Kasai; K Morita; H Ikeda; A Wakisaka; T Yoshiki
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

2.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

3.  Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells.

Authors:  E Méndez; T Kawanishi; K Clemens; H Siomi; S S Soldan; P Calabresi; J Brady; S Jacobson
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines.

Authors:  R Rochford; M J Cannon; R E Sabbe; K Adusumilli; G Picchio; J M Glynn; D J Noonan; D E Mosier; M V Hobbs
Journal:  Viral Immunol       Date:  1997       Impact factor: 2.257

5.  Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.

Authors:  Carina C Ferrari; Amaicha M Depino; Federico Prada; Nara Muraro; Sandra Campbell; Osvaldo Podhajcer; V Hugh Perry; Daniel C Anthony; Fernando J Pitossi
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

6.  Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.

Authors:  T Wyss-Coray; E Masliah; M Mallory; L McConlogue; K Johnson-Wood; C Lin; L Mucke
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

7.  A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution.

Authors:  Laurent Meertens; Sébastien Chevalier; Robert Weil; Antoine Gessain; Renaud Mahieux
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

Review 8.  Interleukin-1: a master regulator of neuroinflammation.

Authors:  Anirban Basu; J Kyle Krady; Steven W Levison
Journal:  J Neurosci Res       Date:  2004-10-15       Impact factor: 4.164

9.  Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis.

Authors:  Michelle Sieburg; Adam Tripp; Jung-Woo Ma; Gerold Feuer
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Evidence for polyomaviruses in human neurological diseases.

Authors:  R T Johnson
Journal:  Prog Clin Biol Res       Date:  1983
View more
  21 in total

1.  Human T cell leukaemia virus type 2 tax protein mediates CC-chemokine expression in peripheral blood mononuclear cells via the nuclear factor kappa B canonical pathway.

Authors:  C S Barrios; L Castillo; H Zhi; C-Z Giam; M A Beilke
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

2.  Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis.

Authors:  Weimin Wang; Jiansuo Zhou; Juan Shi; Yaxi Zhang; Shilian Liu; Yanxin Liu; Dexian Zheng
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CCR5 in human peripheral blood mononuclear cells.

Authors:  Christy S Barrios; Muna Abuerreish; Michael D Lairmore; Laura Castillo; Chou-Zen Giam; Mark A Beilke
Journal:  Viral Immunol       Date:  2011-11-23       Impact factor: 2.257

4.  Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Koichi Ohshima; Tadashi Matsumoto; Masao Matsuoka
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

5.  Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1.

Authors:  Karen M Watters; Jonathan Dean; Virginie Gautier; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

Review 6.  Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research.

Authors:  Mark A Beilke
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02       Impact factor: 2.205

7.  Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.

Authors:  Prabal Banerjee; Adam Tripp; Michael D Lairmore; Lindsey Crawford; Michelle Sieburg; Juan Carlos Ramos; William Harrington; Mark A Beilke; Gerold Feuer
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

8.  Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.

Authors:  Elizabeth Jaworski; Aarthi Narayanan; Rachel Van Duyne; Shabana Shabbeer-Meyering; Sergey Iordanskiy; Mohammed Saifuddin; Ravi Das; Philippe V Afonso; Gavin C Sampey; Myung Chung; Anastas Popratiloff; Bindesh Shrestha; Mohit Sehgal; Pooja Jain; Akos Vertes; Renaud Mahieux; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

Review 9.  HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.

Authors:  John M Taylor; Christophe Nicot
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

Review 10.  Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.

Authors:  Veronique Lepoutre; Pooja Jain; Kevin Quann; Brian Wigdahl; Zafar K Khan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.